110
Participants
Start Date
October 31, 2011
Primary Completion Date
March 31, 2012
Study Completion Date
March 31, 2012
AL-53817 nasal spray solution
Active ingredients administered in 1 of 3 concentrations during Stage A to determine maximum tolerated dose (MTD), and administered at maximum tolerated dose during Stage B.
Vehicle nasal spray
Inactive ingredients used as placebo comparator during Stage A and Stage B.
Alcon Call Center for Trial Locations, Fort Worth
Lead Sponsor
Alcon Research
INDUSTRY